PHYSICAL PERFORMANCE
In a 28-day, randomized, double-blind, placebo-controlled, parallel-design pilot study, 16 professional female Serie A volleyball players participated to evaluate performance outcomes.
CLONAPURE® reduces muscle fatigue in 26.6%
Studies confirmed identical cell viability to creatine monohydrate across all tested concentrations, with no evidence of cytotoxicity. In human trials, no adverse effects were reported, and Clonapure® was well tolerated, confirming its suitability for long-term and daily use.
References:
1. Lapena-Luzon, T., Hernandez-Bueno, A., Tomas Cobos, L., Moreno-Puente, P., Garcia-Benlloch, S., et al. (2025). Evaluation of the Effect of Clonapure® Versus Creatine Monohydrate on ATP Levels in a C2C12 Muscle Cell Line. American Journal of Sports Science, 13(2), 50-56.
2. Colletti, A., Pellizzato, M., HernándezBueno, A., Meo, A. D., Martelli, A., et al. (2025). Effects of Clonapure® Supplementation on Intermittent Aerobic Capacity and Explosive Power in Elite Female Volleyball Players. International Journal of Sports Science and Physical Education, 10(3), 115-123.